News & Media

Working collaboratively with journalists, our team is available to help locate experts, obtain information regarding recent news, and arrange interviews.

For media inquiries, please contact [email protected]

Accelerated cancer drug approvals deliver limited survival gains at high cost

January 18, 2026

Research in Brief: Recapping the Latest Findings from the Institute

November 5, 2025

Checklist

Science diplomacy & 'together shaping the future'

Fulbright Foundation Magazine

typing

Harvard Named a Fulbright ‘Top Producing’ Institution for 2022-2023

The Harvard Crimson

ipad and books in classroom

DPM Faculty Members Recognized by Harvard Medical School for Excellence in Mentoring

September 7, 2022

mentors at table

2022 Gordon Moore Award for Excellence in Mentoring Recipients Named

stock image

Research Recap: February 28 - March 25

stock image

Research Recap: January 3 - 14

February 17, 2022

lightbulb in thought bubble

Oncology Drugs With Accelerated Approval: Is It Time for a Reset?

February 10, 2022

newspaper on subway

2021 in Review: Our Most Engaging Research, a Top 10 List

February 2, 2022

glasses on medical journal article

Studies show substantial spending on cancer drugs that lack documented clinical benefit

December 29, 2021

news on computer

Research Recap: October 11 - November 5

November 29, 2021

lightbulbs

Substantial Spending on Cancer Drugs Without Survival Benefit

October 22, 2021

news on mobile phone

More Patients Receiving Cancer Drugs That Have No Survival Benefit

MedicalResearch.com

October 20, 2021

newspaper bundles

The Price Tag of FDA's 'Onco-Exceptionalism'

October 18, 2021

glasses on newspaper

Two new studies examine rising cancer drug spending in the U.S.

October 18, 2021

stock image

U.S. Spending Up for Cancer Drugs Lacking Evidence of Survival Benefit

October 18, 2021

computer and newspapers

Research Recap: September 13 - September 24

October 13, 2021

Lightbulb 3

Research Recap: July 5 - July 16

Hand holding magnifying glass

Fuzzy OS Benefits in Drug Labels; Zantac Suit Dismissed; Cancer Deaths Drop For Now

glasses on newspaper

‘It’s not a cure’: A gene therapy is opening a new chapter for children, but challenges endure

news on tablet

Financial Pollution: Insight into a new term for wasteful health care spending

Stethoscope and computer

Financial Pollution in the US Health System: a New Metaphor for Wasteful Healthcare Spending

stock photo

Expensive Drugs for Rare Muscle Disease Bring Only Minor Benefits

American Association for the Advancement of Science

November 13, 2020

news on tablet

Celebrating Jim Sabin's leadership of the HPHC Ethics Program

News